Answers are grounded in this paper and cite their sources.
The present study sought to compare how well four established scoring tools, the Padua, Caprini, Wells deep venous thrombosis (DVT) and Autar models, identify DVT among patients with malignant tumors. Between January 2020 and March 2024, 180 patients with cancer who had DVT at Cangzhou Integrated Traditional Chinese and Western Medicine Hospital or Hengshui People's Hospital formed the thrombosis group and another 180 cancer patients treated over the same interval but without DVT served as the controls. The Padua, Caprini and Autar scores were available for all 360 patients. Given that 10 patients with DVT lacked pre‑diagnostic documentation of one or more objective Wells clinical‑sign items, the Wells analyses were restricted to 350 complete cases (170 patients with DVT and 180 controls), without retrospective reconstruction. The present study subsequently examined whether the four scores were associated with DVT occurrence using separate binary logistic regression models and constructed receiver operating characteristic curves to assess discrimination. Scores on the Padua, Caprini and Wells DVT tools were found to be significantly higher in the thrombosis group compared with the controls (all, P<0.001), whereas the Autar scores did not differ significantly between the groups (P=0.856). In the present logistic analysis, higher Padua, Caprini and Wells DVT scores tracked with greater odds of DVT; the area under the curve values were 0.899 for Padua and 0.723 for Caprini in the full cohort and 0.703 for Wells in the 350 complete cases. All three models therefore offer useful prediction of DVT in patients with cancer, with the Padua tool performing best; the Caprini and Wells models were less discriminative and did not differ significantly from each other.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: